Vivaar Exim Private Limited
About Vivaar Exim Private Limited
Data last updated:
Vivaar Exim Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 07 January 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24233DL2013PTC247115.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Meera Pruthi and Rajeev Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at M – 134 2nd Floor Opp. Super Bazar Connaught Place, New Delhi, Delhi, India – 110001.
As per the financials filed for FY 2022, the company reported a revenue of ₹3.12 Lakh. For the same year it recorded a net profit of ₹2.87 Lakh (net margin 92%) and EBITDA of -₹7,900 (EBITDA margin -2.5%).
As per MCA filings, the company has open charges of ₹30 Cr and satisfied charges of ₹50 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Vivaar Exim Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressM – 134 2nd Floor Opp. Super Bazar Connaught Place, New Delhi, Delhi, India – 110001
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Vivaar Exim Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Vivaar Exim Private Limited
FY 2025 filings availableVivaar Exim Private Limited reported revenue of ₹3.12 Lakh for FY 2022.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹3.12 Lakh | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹7,900 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.87 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -2.5% | ||||
| Net Profit Margin | 92% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Vivaar Exim Private Limited, buy the company report.
Board of directors of Vivaar Exim Private Limited
Vivaar Exim has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Meera Pruthi Also directs: Aaloha Lifesciences Private Limited, Vinman Health Private Limited, Quad Lifesciences Private Limited and 1 more | Director | 23 Aug 2021 | 5 Years 2 Months | Current |
| Rajeev Kumar | Director | 23 Aug 2021 | 5 Years 2 Months | Current |
Auditor
Vivaar Exim Private Limited is audited by SKD & Associates for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SKD & Associates | FY 2022 | 023842N |
Shareholding
The shareholding of Vivaar Exim Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Vivaar Exim Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 18 Sep 2013 | 10453060 | Canara Bank | ₹30 Cr | Open | |
| 16 Dec 2015 | 10611714 | Canara Bank | ₹50 Lakh | Satisfied |
To see the full charge records of Vivaar Exim Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Vivaar Exim Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Vivaar Exim Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Vivaar Exim Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Vivaar Exim Private Limited has 6 board changes on record since 2021: 2 appointments and 4 cessations. The latest: Meera Pruthi ceased to be Additional Director on 30 Nov 2021.
1 earlier event is in the company report.
Frequently asked questions
Vivaar Exim is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 07 January 2013 (13+ years old) and is registered under CIN U24233DL2013PTC247115.
Vivaar Exim has 2 current directors:
- Meera Pruthi - Director
- Rajeev Kumar - Director
The latest financial statements of Vivaar Exim on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Vivaar Exim is U24233DL2013PTC247115. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vivaar Exim was incorporated on 07 January 2013, making it 13+ years old. It is registered with the Registrar of Companies, Delhi.
Meera Pruthi ceased to be Additional Director on 30 Nov 2021. Rajeev Kumar ceased to be Additional Director on 30 Nov 2021. Aashish Pruthii ceased to be Director on 16 Oct 2021. Vivaar Exim has 6 board changes on record in total.
The registered office of Vivaar Exim is at M – 134 2nd Floor Opp. Super Bazar Connaught Place, New Delhi, Delhi, India – 110001.
Vivaar Exim operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Vivaar Exim has open charges of ₹30 Cr and satisfied charges of ₹50 Lakh as per latest MCA filings.
The compliance status of Vivaar Exim is compliant as of 25 July 2026. The company is actively filing with the Registrar of Companies.